DAR ZAVAIN received a stock award from RECURSION PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/3/2025ACC: 0001601830-25-000115
Director
Since Apr 2021
+2.92K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
2.92K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+2.92K
Price / share
—
Trade value
—
% of position
2.2%
7/1/2025
132.89K→135.82K
Total
Net shares
+2.92K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 7/1/2025 | A · Award | +2.92K | — | — | 2.2% | 132.89K | 135.82K |
| Total | +2.92K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported